vs
Innoviva, Inc.（INVA）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Innoviva, Inc.的季度营收约是REPUBLIC BANCORP INC的1.2倍（$114.6M vs $94.3M），Innoviva, Inc.净利率更高（143.2% vs 24.2%，领先119.0%），Innoviva, Inc.同比增速更快（24.8% vs 5.3%），过去两年Innoviva, Inc.的营收复合增速更高（21.6% vs -11.5%）
Innoviva Inc是一家专注于呼吸道疾病、传染病及重症护理领域处方治疗药物研发、商业化及特许权使用费管理的医疗保健企业，与全球领先制药商合作，为北美、欧洲等核心市场的患者提供哮喘、慢性阻塞性肺疾病等病症的治疗方案。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
INVA vs RBCAA — 直观对比
营收规模更大
INVA
是对方的1.2倍
$94.3M
营收增速更快
INVA
高出19.5%
5.3%
净利率更高
INVA
高出119.0%
24.2%
两年增速更快
INVA
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.6M | $94.3M |
| 净利润 | $164.2M | $22.8M |
| 毛利率 | 66.0% | — |
| 营业利润率 | 34.0% | 29.3% |
| 净利率 | 143.2% | 24.2% |
| 营收同比 | 24.8% | 5.3% |
| 净利润同比 | 707.4% | 20.0% |
| 每股收益（稀释后） | $2.19 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INVARBCAA
| Q4 25 | $114.6M | $94.3M | ||
| Q3 25 | $107.8M | $93.5M | ||
| Q2 25 | $100.3M | $93.8M | ||
| Q1 25 | $88.6M | $135.8M | ||
| Q4 24 | $91.8M | $89.5M | ||
| Q3 24 | $89.5M | $88.1M | ||
| Q2 24 | $99.9M | $86.9M | ||
| Q1 24 | $77.5M | $120.3M |
净利润INVARBCAA
| Q4 25 | $164.2M | $22.8M | ||
| Q3 25 | $89.9M | $29.7M | ||
| Q2 25 | $63.7M | $31.5M | ||
| Q1 25 | $-46.6M | $47.3M | ||
| Q4 24 | $20.3M | $19.0M | ||
| Q3 24 | $1.2M | $26.5M | ||
| Q2 24 | $-34.7M | $25.2M | ||
| Q1 24 | $36.5M | $30.6M |
毛利率INVARBCAA
| Q4 25 | 66.0% | — | ||
| Q3 25 | 70.1% | — | ||
| Q2 25 | 82.9% | — | ||
| Q1 25 | 82.7% | — | ||
| Q4 24 | 85.1% | — | ||
| Q3 24 | 81.6% | — | ||
| Q2 24 | 85.1% | — | ||
| Q1 24 | 77.5% | — |
营业利润率INVARBCAA
| Q4 25 | 34.0% | 29.3% | ||
| Q3 25 | 32.1% | 40.4% | ||
| Q2 25 | 48.6% | 43.0% | ||
| Q1 25 | 46.7% | 44.1% | ||
| Q4 24 | 47.0% | 25.8% | ||
| Q3 24 | 48.3% | 38.4% | ||
| Q2 24 | 54.7% | 37.0% | ||
| Q1 24 | 33.3% | 32.2% |
净利率INVARBCAA
| Q4 25 | 143.2% | 24.2% | ||
| Q3 25 | 83.4% | 31.8% | ||
| Q2 25 | 63.5% | 33.5% | ||
| Q1 25 | -52.6% | 34.8% | ||
| Q4 24 | 22.1% | 21.2% | ||
| Q3 24 | 1.4% | 30.1% | ||
| Q2 24 | -34.7% | 29.0% | ||
| Q1 24 | 47.1% | 25.4% |
每股收益（稀释后）INVARBCAA
| Q4 25 | $2.19 | — | ||
| Q3 25 | $1.08 | — | ||
| Q2 25 | $0.77 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $0.43 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.55 | — | ||
| Q1 24 | $0.46 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $550.9M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $1.1B |
| 总资产 | $1.6B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INVARBCAA
| Q4 25 | $550.9M | $220.0M | ||
| Q3 25 | $476.5M | $484.2M | ||
| Q2 25 | $397.5M | $484.8M | ||
| Q1 25 | $319.1M | $793.0M | ||
| Q4 24 | $305.0M | $432.2M | ||
| Q3 24 | $260.6M | $530.9M | ||
| Q2 24 | $217.0M | $400.1M | ||
| Q1 24 | $178.4M | $546.4M |
股东权益INVARBCAA
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.0B | $1.1B | ||
| Q2 25 | $714.8M | $1.1B | ||
| Q1 25 | $646.9M | $1.0B | ||
| Q4 24 | $691.2M | $992.0M | ||
| Q3 24 | $668.5M | $979.7M | ||
| Q2 24 | $665.5M | $955.4M | ||
| Q1 24 | $703.7M | $935.6M |
总资产INVARBCAA
| Q4 25 | $1.6B | $7.0B | ||
| Q3 25 | $1.4B | $7.0B | ||
| Q2 25 | $1.3B | $7.0B | ||
| Q1 25 | $1.3B | $7.1B | ||
| Q4 24 | $1.3B | $6.8B | ||
| Q3 24 | $1.2B | $6.7B | ||
| Q2 24 | $1.2B | $6.6B | ||
| Q1 24 | $1.3B | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.5M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | 0.33× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流INVARBCAA
| Q4 25 | $54.5M | $168.2M | ||
| Q3 25 | $49.7M | $33.3M | ||
| Q2 25 | $44.1M | $8.4M | ||
| Q1 25 | $48.6M | $93.2M | ||
| Q4 24 | $59.2M | $149.0M | ||
| Q3 24 | $48.7M | $51.3M | ||
| Q2 24 | $43.7M | $4.0M | ||
| Q1 24 | $37.0M | $71.2M |
自由现金流INVARBCAA
| Q4 25 | — | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | $48.4M | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率INVARBCAA
| Q4 25 | — | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | 54.1% | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度INVARBCAA
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率INVARBCAA
| Q4 25 | 0.33× | 7.37× | ||
| Q3 25 | 0.55× | 1.12× | ||
| Q2 25 | 0.69× | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | 2.91× | 7.84× | ||
| Q3 24 | 40.14× | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | 1.01× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INVA
| Royalty | $54.9M | 48% |
| Xacduro | $32.1M | 28% |
| Giapreza | $19.6M | 17% |
| Xerava | $7.3M | 6% |
RBCAA
暂无分部数据
